| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/24/2010 | US20100158939 Vaccine against pandemic strains of influenza viruses |
| 06/24/2010 | US20100158938 Tetravalent Dengue Vaccines |
| 06/24/2010 | US20100158870 Novel bacteriophage and antibacterial composition comprising the same |
| 06/24/2010 | CA2746310A1 Methods and compositions for use of a coccidiosis vaccine |
| 06/23/2010 | EP2198016A1 Porcine adeno-associated viruses |
| 06/23/2010 | EP2197283A2 Formulations for preservation of rota virus |
| 06/23/2010 | EP1108036B1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 06/23/2010 | CN1930284B Infectious bursal disease virus antigenic isolates and vaccines |
| 06/23/2010 | CN1655827B Novel use of adenoviruses and nucleic acids coding therefor |
| 06/23/2010 | CN101748123A Manufacturing method of adjustable liver damage animal model and special DNA fragment thereof |
| 06/23/2010 | CN101748122A Disturbing molecule for inhibiting expression of TM4SF4 and application thereof |
| 06/23/2010 | CN101748102A Method for production of porcine epidemic diarrhea virus |
| 06/23/2010 | CN101748101A Method for producing porcine reproductive and respiratory syndrome viruses |
| 06/23/2010 | CN101745109A Method for preparing nasal-spray type influenza virus vaccine containing CpG ODN and poly I:G adjuvant |
| 06/23/2010 | CN101745108A Avian influenza vaccine and preparation method thereof |
| 06/22/2010 | US7741434 High-affinity antagonists of ELR-CXC chemokines |
| 06/22/2010 | US7741099 Recombinant, replication defective viral particles comprising chimeric hexon protein and hyper variable regions for use in improved gene delivery, vaccination, and gene therapy |
| 06/22/2010 | US7741098 Plasmid vector for expression in caenorhabditis elegans and in escherichia coli; heterologous gene expression |
| 06/22/2010 | US7741079 Method of making a genetically modified mammalian cell |
| 06/22/2010 | CA2347973C Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 06/17/2010 | WO2010068939A2 Bioactive grafts and composites |
| 06/17/2010 | WO2010068102A1 Novel plant virus |
| 06/17/2010 | WO2010067109A1 Anti-viral protection with viruses containing defective genome segments |
| 06/17/2010 | WO2010067013A1 Novel isolated reovirus, and detection methods and kits |
| 06/17/2010 | US20100152282 Use of double stranded rna hairpin duplexes in gene silencing |
| 06/17/2010 | US20100151556 Hybrid and single chain meganucleases and use thereof |
| 06/17/2010 | US20100151441 Human Cytomegalovirus Latency Promoting Genes, Related Virus Variants and Methods of Use |
| 06/17/2010 | US20100150961 Virus like particle purification |
| 06/17/2010 | US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION |
| 06/17/2010 | DE102008028406B4 Anzucht und Vermehrung des Norovirus in vitro Cultivation and propagation of norovirus in vitro |
| 06/17/2010 | CA2746668A1 Bioactive grafts and composites |
| 06/17/2010 | CA2746495A1 Anti-viral protection with viruses containing a defective genome |
| 06/17/2010 | CA2744938A1 Modification of nucleic acid vectors |
| 06/16/2010 | EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 06/16/2010 | EP2196217A1 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/16/2010 | EP2196215A1 Method for making an immunogenic composition with Hoc fusion proteins and Soc fusion proteins |
| 06/16/2010 | EP2196214A1 Method for making an immunogenic composition with Hoc fusion proteins and/or Soc fusion proteins |
| 06/16/2010 | EP2195430A2 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 06/16/2010 | EP2195419A1 Methods for drying bacteriophage and bacteriophage-containing compositions, the resulting dry compositions, and methods of use |
| 06/16/2010 | EP2195418A1 Process and system for the industrial scale purification of bacteriophages intended for bacteriophage therapy |
| 06/16/2010 | EP2195021A1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
| 06/16/2010 | EP1627917B1 NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO |
| 06/16/2010 | EP1495125B1 Vac-bac shuttle vector system |
| 06/16/2010 | EP1234024B2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/16/2010 | CN1582333B Live vaccine and method of manufacture |
| 06/16/2010 | CN101736006A Method for recombinant expression of soluble transcription mediator complex Med23 subunit |
| 06/16/2010 | CN101735990A Method for purifying recombinant sendai virus vector |
| 06/16/2010 | CN101732711A Preparation of nose-spraying flu immunization pentavalent or multivalent inactivated vaccine and application thereof |
| 06/16/2010 | CN101732709A Method for preparing haemorrhagic fever vaccine by culturing primary cells in multilayer culture flask |
| 06/16/2010 | CN101732708A Preparation method of vaccine for epidemic encephalitis B |
| 06/16/2010 | CN101307305B Low virulent strain of porcine reproductive and respiratory syndrome virus, immunogenicity immunogenicity material and vaccine |
| 06/16/2010 | CN101084011B Porcine reproductive and respiratory syndrome virus strains and compositions |
| 06/16/2010 | CN101031651B Cell for producing retrovirus vector |
| 06/15/2010 | US7736850 Strain of SARS-associated coronavirus and applications thereof |
| 06/15/2010 | US7736847 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 06/15/2010 | US7736640 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 06/10/2010 | WO2010065911A1 Compositions, methods and uses for inducing viral growth |
| 06/10/2010 | WO2010065414A1 Use of micrornas to control virus helper nucleic acids |
| 06/10/2010 | WO2010064950A1 Biopreparation for neutralising bacillus anthracis spores and vegetative cells |
| 06/10/2010 | WO2010064949A1 Biopreparation for neutralising bacillus anthracis spores and vegetative cells |
| 06/10/2010 | WO2010064772A1 Novel bacteriophage and antibacterial composition containing the same |
| 06/10/2010 | WO2010064164A1 Bovine viral diarrhea virus with a modified erns protein |
| 06/10/2010 | WO2010064044A1 Methods for bacteriophage design |
| 06/10/2010 | WO2010063804A1 Novel method for generation of rna virus |
| 06/10/2010 | US20100146659 Plant Virus Designated Tomato Marchitez Virus |
| 06/10/2010 | US20100146653 Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus |
| 06/10/2010 | US20100145015 Compositions and methods for increasing immunogenicity of glycoprotein vaccines |
| 06/10/2010 | US20100144040 Cells and methodology to generate non-segmented negative-strand rna viruses |
| 06/10/2010 | US20100144016 Apparatus for the disruption of animal cells |
| 06/10/2010 | US20100144015 Compositions, methods and uses for inducing viral growth |
| 06/10/2010 | US20100144014 Method for amplifying hcv in aedes mosquitoes |
| 06/10/2010 | US20100143889 Rhabdoviridae virus preparations |
| 06/10/2010 | US20100143409 Generation of virus-like particles and use as panfilovirus vaccines |
| 06/10/2010 | US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 06/10/2010 | US20100143406 Methods of enhancing protein incorporation into virus like particles |
| 06/10/2010 | US20100143402 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus |
| 06/10/2010 | US20100143392 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
| 06/10/2010 | US20100143376 Antibodies Specific for Rubella Virus |
| 06/10/2010 | US20100143309 Viral vectors |
| 06/10/2010 | US20100143302 Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof |
| 06/10/2010 | CA2745962A1 Compositions, methods and uses for inducing viral growth |
| 06/10/2010 | CA2745604A1 Methods for bacteriophage design |
| 06/10/2010 | CA2745259A1 Novel method for generation of rna virus |
| 06/10/2010 | CA2744750A1 Bovine viral diarrhea virus with a modified erns protein |
| 06/09/2010 | EP2194137A2 Cells comprising codon optimized retroviral particles |
| 06/09/2010 | EP2194127A1 Primate T-Lymphotropic viruses |
| 06/09/2010 | EP2192917A1 Method for producing viral vaccines |
| 06/09/2010 | EP1326988B1 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 06/09/2010 | EP0863202B1 Recombinant sendai virus |
| 06/09/2010 | CN101724636A Asial type foot-and-mouth disease virus (FMDV) infectious cDNA and construction method as well as application thereof |
| 06/09/2010 | CN101724608A Recombined I type herpes simplex virus used for recombined AAV2/8 virus carrier production and application thereof |
| 06/09/2010 | CN101724607A Bacteriophage EK99-C of enterotoxigenic Escherichia coil ETEC-K99 and application thereof |
| 06/09/2010 | CN101724606A Porcine circoviruses, vaccines and diagnostic reagents |
| 06/09/2010 | CN101280316B Therapeutic vaccine for human cervical carcinoma |
| 06/09/2010 | CN101245326B Concentration method for virus or bacteria |
| 06/08/2010 | US7732129 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation |
| 06/08/2010 | US7731975 Chimeric filovirus glycoprotein |
| 06/08/2010 | US7731974 a mutant rhabdovirus having one or more mutation in a gene encoding a protein involved in blocking nuclear transport of mRNA or protein in an infected cells; capable of triggering the anti-viral systems of normal host cells; anticarcinogenic agent; vaccine adjuvant, vaccine vector |
| 06/08/2010 | US7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 06/08/2010 | US7731951 Viruses for the treatment of cellular proliferative disorders |